KemPharm, Inc. (KMPH): Price and Financial Metrics

KMPH POWR Grades

• Value is the dimension where KMPH ranks best; there it ranks ahead of 85.14% of US stocks.
• KMPH's strongest trending metric is Growth; it's been moving down over the last 179 days.
• KMPH ranks lowest in Stability; there it ranks in the 5th percentile.

KMPH Stock Summary

• With a year-over-year growth in debt of -97.56%, Kempharm Inc's debt growth rate surpasses only 1.7% of about US stocks.
• As for revenue growth, note that KMPH's revenue has grown 131.21% over the past 12 months; that beats the revenue growth of 93.76% of US companies in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for KMPH comes in at -62.86% -- higher than that of only 6.8% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Kempharm Inc, a group of peers worth examining would be ALBO, EPZM, INFN, KPTI, and RDUS.
• KMPH's SEC filings can be seen here. And to visit Kempharm Inc's official web site, go to kempharm.com.

KMPH Valuation Summary

• In comparison to the median Healthcare stock, KMPH's price/earnings ratio is 224.66% lower, now standing at -45.5.
• KMPH's price/sales ratio has moved NA NA over the prior 78 months.
• KMPH's price/sales ratio has moved NA NA over the prior 78 months.

Below are key valuation metrics over time for KMPH.

KMPH Growth Metrics

Its 2 year net income to common stockholders growth rate is now at 66.25%.
• Its 3 year net cashflow from operations growth rate is now at -154.15%.
• Its 3 year price growth rate is now at -80.07%.

Over the past 49 months, KMPH's revenue has gone up $28,434,000.

The table below shows KMPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	28.434	10.228	-65.05
2021-06-30	28.394	11.907	-66.3
2021-03-31	23.316	-2.503	-54.746
2020-12-31	13.288	-1.939	-12.76
2020-09-30	12.298	-3.978	-13.941
2020-06-30	21.836	-5.156	-7.869

KMPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• KMPH has a Quality Grade of B, ranking ahead of 90.29% of graded US stocks.
• KMPH's asset turnover comes in at 0.451 -- ranking 100th of 682 Pharmaceutical Products stocks.
• NAII, ACUR, and EGRX are the stocks whose asset turnover ratios are most correlated with KMPH.

The table below shows KMPH's key quality metrics over time.